Case Report: Long-Acting Oral Cariprazine

Case Report: Long-Acting Oral Cariprazine

IntroductionCariprazine is a third-generation antipsychotic, approved for the treatment of schizophrenia and bipolar disorder and used off-label for schizoaffective disorder and treatment-resistant depression. Cariprazine is a partial agonist at dopamine receptors D2 and D3 and serotonin receptor 5H...

Full description

Bibliographic Details
Main Authors: Emanuela Dyrmishi, Marco De Pieri, Marco Ferrari, Rafael Traber, Matteo Preve, Luca De Peri, Emilio Bolla
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Psychiatry
Subjects:
long acting antipsychotics
cariprazine
therapeutic alliance
personalized medicine
adherence–compliance–persistence
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2022.876003/full

Internet

https://www.frontiersin.org/articles/10.3389/fpsyt.2022.876003/full

Similar Items